Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Prolactin may be important for skin growth and immune function.

New treatments aim to improve thin endometrium to help more couples with infertility.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

The skin is a complex barrier that protects the body, regulates temperature, and helps with immune responses.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Prolactin may affect hair growth differently based on gender and scalp area.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Using neurohormones to control keratin can lead to new skin disease treatments.